首页> Cureus> Assessing the Impact of All-Trans Retinoic Acid (ATRA)- and Arsenic Trioxide (ATO)-Based Therapy in Pediatric Acute Promyelocytic Leukemia: A Single-Center Study.

Assessing the Impact of All-Trans Retinoic Acid (ATRA)- and Arsenic Trioxide (ATO)-Based Therapy in Pediatric Acute Promyelocytic Leukemia: A Single-Center Study.

导出 LinkOut

翻译打印收藏纠错

第一作者： Reshma,Roshan

第一单位： Clinical Hematology, Sher-i-Kashmir Institute of Medical Sciences (SKIMS), Srinagar, IND.

作者： Reshma,Roshan ^[1] ; Mubashir H,Shah ^[2] ; Sherook,J ^[1] ; Aidel F,Parry ^[1] ; Javid R,Bhat ^[1]

作者单位： Clinical Hematology, Sher-i-Kashmir Institute of Medical Sciences (SKIMS), Srinagar, IND. ^[1] Department of Pediatrics, Government Medical College Srinagar, Srinagar, IND. ^[2]

关键词 acute myeloid leukemia (aml)high-risk patients induction therapy pediatric patients pml-rara fusion gene risk stratification treatment regimen

DOI 10.7759/cureus.89081

PMID 40896003

发布时间 2025-09-15

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Cureus

2025年17卷7期

e89081页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

Cureus

2025年17卷7期

e89081页

检索历史清除

Assessing the Impact of All-Trans Retinoic Acid (ATRA)- and Arsenic Trioxide (ATO)-Based Therapy in Pediatric Acute Promyelocytic Leukemia: A Single-Center Study.

Cureus

相似文献

同项目论文

Cureus

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Assessing the Impact of All-Trans Retinoic Acid (ATRA)- and Arsenic Trioxide (ATO)-Based Therapy in Pediatric Acute Promyelocytic Leukemia: A Single-Center Study.

Cureus

相似文献

同项目论文

Cureus

相关期刊

检索历史清除